Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $10.72 and traded as high as $10.84. Ono Pharmaceutical shares last traded at $10.84, with a volume of 1,326 shares trading hands.
Ono Pharmaceutical Stock Performance
The business’s 50-day moving average price is $10.72 and its 200 day moving average price is $12.86. The company has a market cap of $5.57 billion, a P/E ratio of 8.09 and a beta of 0.59.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- 3 Monster Growth Stocks to Buy Now
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Options Trading – Understanding Strike Price
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- CD Calculator: Certificate of Deposit Calculator
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
